Events
-
Acceleron Secures $30M Private Financing
+ VIEW FULL Event -
Acceleron Pharma to Present at Two Upcoming Investor Conferences
+ VIEW FULL Event -
Acceleron Pharma to Present at Two September Investor Conferences
+ VIEW FULL Event -
Acceleron Pharma Presents Anabolic Bone Effects of ACE-661 at International Scientific Meeting
+ VIEW FULL Event -
Acceleron Presents Positive Results from Phase 1 Study of ACE-041 in Patients with Advanced Cancer
+ VIEW FULL Event -
Acceleron Pharma to Present at Two Upcoming Investor Conferences in April
+ VIEW FULL Event -
Acceleron Announces Interim Findings from the ACE-041 Phase 1, First-in-Human Clinical Trial at 22nd EORTC-NCI-AACR Symposium
+ VIEW FULL Event -
Acceleron Presents Preliminary ACE-031 Results from a Phase 1 Multiple Ascending Dose Study in Healthy Volunteers
+ VIEW FULL Event -
Acceleron to Present at the Cowen and Company 30th Annual Health Care Conference
+ VIEW FULL Event -
Acceleron Pharma Announces Addition of Two Novel Programs to Development Pipeline at the 28th Annual JP Morgan Healthcare Conference
+ VIEW FULL Event -
Acceleron Pharma to Present at the 28th Annual J.P. Morgan Healthcare Conference
+ VIEW FULL Event -
Acceleron Pharma Presents Findings of ACE-536, a Novel Red Blood Cell-Forming Agent, at the 51st Annual Meeting of the American Society of Hematology
+ VIEW FULL Event -
Acceleron Pharma to Present Data on ACE-011 and ACE-536 at the 51st Annual Meeting of the American Society of Hematology
+ VIEW FULL Event -
Acceleron to Present at the UBS Global Life Sciences Conference
+ VIEW FULL Event -
Acceleron to Present at the BMO Capital Markets 9th Annual Focus on Healthcare Conference
+ VIEW FULL Event -
Acceleron to Present ACE-031 Preclinical Study Results as Treatment for Loss of Muscle Mass and Function
+ VIEW FULL Event -
Acceleron Pharma to Present at Two Upcoming Investor Conferences
+ VIEW FULL Event -
Acceleron Pharma Presents Preclinical Study Results for ACE-041 at the AACR 100th Annual Meeting 2009
+ VIEW FULL Event -
Acceleron to Present at the BioCentury Future Leaders in the Biotech Industry Conference
+ VIEW FULL Event -
Acceleron to Present at the Cowen and Company 29th Annual Health Care Conference
+ VIEW FULL Event -
Acceleron Introduces Breakthrough Program for Treatment of Anemia at the 27th Annual JP Morgan Healthcare Conference
+ VIEW FULL Event -
Acceleron to Present at the 27th Annual JP Morgan Healthcare Conference
+ VIEW FULL Event -
Celgene Corporation and Acceleron Pharma to Present ACE-011 Data at the 50th Annual Meeting of the American Society of Hematology
+ VIEW FULL Event -
Acceleron to Present at the Oppenheimer 19th Annual Health Care Conference
+ VIEW FULL Event -
Acceleron to Present at the 7th Annual Biotechnology Industry Organization Investor Forum
+ VIEW FULL Event -
Acceleron to Present at Third Annual JMP Securities Healthcare Focus Conference
+ VIEW FULL Event -
Acceleron to Present at the UBS Global Life Sciences Conference
+ VIEW FULL Event -
Acceleron to Present at the Jefferies 2nd Annual Healthcare Conference
+ VIEW FULL Event -
Acceleron to Present at the Needham & Company 7th Annual Biotechnology and Medical Technology Conference
+ VIEW FULL Event -
Acceleron to Present at the Rodman & Renshaw 5th Annual Global Healthcare Conference
+ VIEW FULL Event -
Acceleron to Present at the Cowen and Company 28th Annual Health Care Conference
+ VIEW FULL Event -
Acceleron Pharma to Present at the Lazard Capital Markets Fourth Annual Healthcare Conference
+ VIEW FULL Event -
Acceleron Pharma to Present at the Massachusetts Biotechnology Council’s 9th Annual MASS Opportunities Investment Conference
+ VIEW FULL Event -
Acceleron Pharma to Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
+ VIEW FULL Event -
Acceleron Pharma’s ACE-031 Increases Muscle Mass In a Preclinical Model of Glucocorticoid-induced Muscle Loss
+ VIEW FULL Event -
Acceleron Pharma to Present at the Natixis Bleichroeder Hidden Gems Conference
+ VIEW FULL Event -
Acceleron Pharma’s ACE-011 Increases Bone Mineral Density and Bone Strength in Preclinical Studies in Non-Human Primates
+ VIEW FULL Event -
Acceleron Pharma to Present at the UBS 2007 Global Life Sciences Conference
+ VIEW FULL Event -
Acceleron Pharma Presents Positive Phase 1 Results Demonstrating ACE-011 Increases Markers of Bone Formation
+ VIEW FULL Event -
Acceleron Pharma to Present ACE-011 Bone Growth Data at the ASBMR 29th Annual Meeting
+ VIEW FULL Event -
Acceleron Pharma to Present at the 27th Annual Canaccord Adams Global Growth Conference
+ VIEW FULL Event -
ACE-011 Improves Multiple Myeloma Bone Disease in a Preclinical Model
+ VIEW FULL Event -
Acceleron Pharma’s ACE-031 Increases Muscle Mass and Strength in Preclinical Studies
+ VIEW FULL Event -
Acceleron Pharma to Present at the Cowen 27th Annual Health Care Conference
+ VIEW FULL Event -
Acceleron Pharma to Present at the Rodman & Renshaw 8th Annual Healthcare Conference
+ VIEW FULL Event -
Acceleron Pharma to Present at the MBC’s MASS Opportunities Conference
+ VIEW FULL Event -
Acceleron Pharma Presents ACE-011 Preclinical Data Demonstrating Both Anabolic and Anti-Resorptive Properties
+ VIEW FULL Event -
Acceleron Pharma to Present ACE-011 Preclinical Data at the Annual Meeting of the American Society for Bone and Mineral Research
+ VIEW FULL Event